This study cannot be trusted to guide treatment decisions because it was poorly designed, had no comparison group, included too few patients, and was later withdrawn due to evidence of fraud in its peer review process.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether retracted studies on I-131 and DNA damage have led to inappropriate clinical guidelines or patient harm.
A systematic review of all retracted studies on I-131 therapy in thyroid cancer, assessing whether they were cited in clinical guidelines, patient information materials, or media reports, and whether they influenced treatment decisions.
Whether clinicians who cited this retracted study altered I-131 prescribing patterns in PTC patients.
A cohort study of 500 endocrinologists in the U.S. and Europe, assessing changes in I-131 prescribing rates for low-risk PTC before and after publication and retraction of this study, using prescription databases and survey data.
Whether medical students or clinicians believe this retracted study provides valid evidence for avoiding I-131.
A cross-sectional survey of 1,000 medical trainees and clinicians assessing their perception of the validity of this study’s conclusions and whether they would recommend avoiding I-131 based on it.
Whether a patient was denied I-131 therapy based on this retracted study and experienced adverse outcomes.
A case series of 5 patients with intermediate-risk PTC who were denied I-131 based on this study, documenting recurrence rates and clinical outcomes compared to matched controls who received I-131.
Whether expert bodies consider this retracted study a cautionary example of flawed science in nuclear medicine.
A narrative review by a panel of nuclear medicine and ethics experts analyzing this retracted study as a case of research misconduct and its implications for clinical decision-making.